2Spaide RF, Yannuzzi LA, Slakter JS, et al. Indocyanine green videoangiography of idiopathic polypoidal choroidal vasculopathy.Retina, 1995,15:100-110.
3Yannuzzi LA, Ciardella A, Spaide RF, et al. The expanding clinical spectrum of idiopathic polypoidal choroidal vasculopathy. Arch Ophthalmol, 1997,115:478-485.
4Moorthy RS, Lyon AT, Rabb MF, et al.Idiopathic polypoidal choroidal vasculopathy of the macula.Ophthalmology, 1998,105:1380-1385.
5Bethea D, Fullmer B, Syed S, et al. Psoralen photobiology and photochemotherapy: 50 years of science and medicine. J Dermatol Sci, 1999, 19:78-88.
6Miller JW, Waish AW, Kramer M, et al. Photodynamic therapy of experimental choroidal neovascularization using lipoprotein- delivered benzoporphyrin. Arch Ophthalmol, 1995, 113: 810- 818.
7Maeular Photoeoagulation Study Group. Argon laser photocoagulation for neovascular maculopathy: five-year results from randomised clinical trials. Arch Ophthalmol, 1991, 109: 1109-1114.
8Treatment of Age-related Macular Degeneration With Photodynamic Therapy Study Group. Photodynamic therapy ofsubfoveal choroidal neovascularization in age-related maeular degeneration with verteporfin: one-year results of 2 randomized clinical trials-TAP report 1. Arch Ophthalmol, 1999, 117: 1329-1345.
9Treatment of Age-Related Macular Degeneration With Photodynamic Therapy Study Group. Photodynamic therapy of subfoveal choroidal neovascularization in age-related maculardegeneration with verteporfin: two-year results of 2 randomized clinical trials-TAP report 2. Arch Ophthalmol, 2001, 119: 198- 207.
10Japanese Age-Related Macular Degeneration Tial (JAT) Study Group. Japanese age-related macular degeneration trial: 1-year results of photodynamic therapy with verteporfin in Japanesepatients with subfoveal choroidal neovascularization secondary to age-related macular degeneration. Am J Ophthalmol, 2003, 136 : 1049-1061.
